Anson Funds Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-22,960
Closed -$367K 315
2020
Q4
$367K Sell
22,960
-13,040
-36% -$161K 0.07% 130
2020
Q3
$439K Buy
+36,000
New +$520K 0.24% 76

Other funds holding RNLX

Anson Funds Management's RNLX Position: Q1 2021 in Review

Anson Funds Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2021, closing a stake of 22,960 shares — an estimated $367K sold.

Anson Funds Management first reported a position in RNLX in Q3 2020 and held it in 2 quarters. The position peaked at $439K in Q3 2020. 38 funds tracked by Wall St. Rank hold RNLX as of Q1 2021.

  • Anson Funds Management reported no remaining Renalytix plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Anson Funds Management sold 22,960 Renalytix plc American Depositary Shares shares in Q1 2021, an estimated $367K.
  • Anson Funds Management first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and held it in 2 quarters.
  • Anson Funds Management's Renalytix plc American Depositary Shares position peaked at $439K in Q3 2020.
  • 38 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2021.

Based on Anson Funds Management's 13F filing for Q1 2021, filed 14 May 2021.